1. Home
  2. RNXT vs MYND Comparison

RNXT vs MYND Comparison

Compare RNXT & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • MYND
  • Stock Information
  • Founded
  • RNXT 2012
  • MYND 1998
  • Country
  • RNXT United States
  • MYND United States
  • Employees
  • RNXT N/A
  • MYND N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • MYND Other Consumer Services
  • Sector
  • RNXT Health Care
  • MYND Real Estate
  • Exchange
  • RNXT Nasdaq
  • MYND Nasdaq
  • Market Cap
  • RNXT 44.6M
  • MYND 38.8M
  • IPO Year
  • RNXT 2021
  • MYND 2017
  • Fundamental
  • Price
  • RNXT $1.40
  • MYND $0.85
  • Analyst Decision
  • RNXT Strong Buy
  • MYND
  • Analyst Count
  • RNXT 2
  • MYND 0
  • Target Price
  • RNXT $7.00
  • MYND N/A
  • AVG Volume (30 Days)
  • RNXT 210.6K
  • MYND 49.6K
  • Earning Date
  • RNXT 05-15-2025
  • MYND 06-10-2025
  • Dividend Yield
  • RNXT N/A
  • MYND N/A
  • EPS Growth
  • RNXT N/A
  • MYND N/A
  • EPS
  • RNXT N/A
  • MYND N/A
  • Revenue
  • RNXT $240,000.00
  • MYND $267,380,999.00
  • Revenue This Year
  • RNXT $3,927.91
  • MYND N/A
  • Revenue Next Year
  • RNXT $219.75
  • MYND N/A
  • P/E Ratio
  • RNXT N/A
  • MYND N/A
  • Revenue Growth
  • RNXT N/A
  • MYND N/A
  • 52 Week Low
  • RNXT $0.75
  • MYND $0.61
  • 52 Week High
  • RNXT $1.69
  • MYND $3.89
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 78.13
  • MYND 53.77
  • Support Level
  • RNXT $1.17
  • MYND $0.82
  • Resistance Level
  • RNXT $1.30
  • MYND $0.87
  • Average True Range (ATR)
  • RNXT 0.08
  • MYND 0.05
  • MACD
  • RNXT 0.02
  • MYND 0.00
  • Stochastic Oscillator
  • RNXT 100.00
  • MYND 63.72

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

Share on Social Networks: